Bruce Pollock - Publications

Affiliations: 
University of Toronto (CAMH), Toronto, Ontario, Canada 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sakurai H, Suzuki T, Bies RR, Pollock BG, Mimura M, Kapur S, Uchida H. Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: 1381-1390. PMID 27788310 DOI: 10.4088/JCP.15m10490  0.52
2016 Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R. R-and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. British Journal of Clinical Pharmacology. PMID 27145364 DOI: 10.1111/bcp.12997  0.52
2016 Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study. Human Psychopharmacology. PMID 27060853 DOI: 10.1002/hup.2532  0.52
2015 Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. Journal of Pharmacokinetics and Pharmacodynamics. PMID 26611790 DOI: 10.1007/s10928-015-9457-6  0.52
2015 Nakajima S, Uchida H, Bies RR, Caravaggio F, Suzuki T, Plitman E, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Mamo DC, Graff-Guerrero A. Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. PMID 26221049 DOI: 10.1093/schbul/sbv106  0.52
2015 Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. Jama Psychiatry. 72: 927-34. PMID 26131622 DOI: 10.1001/jamapsychiatry.2015.0891  0.4
2015 Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD. Clinical Pharmacokinetics. PMID 25971243 DOI: 10.1007/s40262-015-0275-1  0.52
2015 Tsuboi T, Suzuki T, Bies RR, Remington G, Pollock BG, Mimura M, Uchida H. Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study. Schizophrenia Research. 164: 149-54. PMID 25864950 DOI: 10.1016/j.schres.2015.03.025  0.52
2009 Bigos KL, Pollock BG, Stankevich BA, Bies RR. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gender Medicine. 6: 522-43. PMID 20114004 DOI: 10.1016/j.genm.2009.12.004  0.52
2008 Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 3221-5. PMID 18463627 DOI: 10.1038/npp.2008.52  0.4
2008 Bigos KL, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M, Kirshner MA, Schneider LS, Bies RR. Sex, race, and smoking impact olanzapine exposure. Journal of Clinical Pharmacology. 48: 157-65. PMID 18199892 DOI: 10.1177/0091270007310385  0.4
2006 Bigos KL, Bies RR, Pollock BG. Population pharmacokinetics in geriatric psychiatry. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 993-1003. PMID 17138806 DOI: 10.1097/01.JGP.0000224330.73063.6c  0.52
2006 Fabian TJ, Schwartzman DS, Ujhelyi MR, Corey SE, Bigos KL, Pollock BG, Kroboth PD. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. Journal of Cardiovascular Electrophysiology. 17: 391-5. PMID 16643361 DOI: 10.1111/j.1540-8167.2006.00416.x  0.4
2003 Bies RR, Bigos KL, Pollock BG. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants. The Journal of Gender-Specific Medicine : Jgsm : the Official Journal of the Partnership For Women's Health At Columbia. 6: 12-20. PMID 14513571  0.52
2003 Kroboth PD, Amico JA, Stone RA, Folan M, Frye RF, Kroboth FJ, Bigos KL, Fabian TJ, Linares AM, Pollock BG, Hakala C. Influence of DHEA administration on 24-hour cortisol concentrations. Journal of Clinical Psychopharmacology. 23: 96-9. PMID 12544381 DOI: 10.1097/00004714-200302000-00014  0.4
Show low-probability matches.